ArticleMolecular therapy : the journal of the American Society of Gene Therapy2024

CRISPR-mediated ablation of TP53 and EGFR mutations enhances gefitinib sensitivity and anti-tumor efficacy in lung cancer.

A-Rum Yoon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.